[Vaccine coverage and levels of protection with triple viral vaccine in a children population].
The purpose of this study is to know the immunity status of children in 10th area of Madrid and the effectiveness of vaccination campaigns against rubella, mumps and measles. An epidemiological interview together with ELISA have been used to determine the antibodies rates. 87.8%, 77.3% and 69.3% children studied were found to have immunoprotection against this viral infections. These rates are lower than those recommended by WHO; however, by age groups, the study shows statistically significant increase in children aged 5 years or less, what means a progressive acceptance of measles, rubella and mumps vaccination by population.
Sánchez Serrano
L P
LP
Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid.
Corcuera
M T
MT
Molina
M P
MP
de Miguel
C
C
Lozano
J
J
Oñorbe
J A
JA
Barberá
G
G
D000914:Antibodies, Viral / Q000032:analysis*; D002675:Child, Preschool; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008458:Measles Vaccine / Q000276:immunology*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000276:immunology*; D012411:Rubella Vaccine / Q000276:immunology*; D013030:Spain
D000914:Antibodies, Viral; D004338:Drug Combinations; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine
Cobertura vacunal y niveles de protección frente a la vacuna triple vírica en una población infantil.